A randomised controlled trial of perineural vs intravenous dexamethasone for foot surgery

Date

2016

Authors

Dawson, R.
Mcleod, D.
Koerber, J.
Plummer, J.
Dracopoulos, G.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Anaesthesia, 2016; 71(3):285-290

Statement of Responsibility

R. L. Dawson, D. H. McLeod, J. P. Koerber, J. L. Plummer, G. C. Dracopoulos

Conference Name

Abstract

We used 20 ml ropivacaine 0.75% for ankle blocks before foot surgery in 90 participants who we allocated in equal numbers to: perineural dexamethasone 8 mg and intravenous saline 0.9%; perineural saline 0.9% and intravenous dexamethasone 8 mg; or perineural and intravenous saline 0.9%. Dexamethasone increased the median (IQR [range]) time for the return of some sensation or movement, from 14.6 (10.8-18.8 [5.5-38.0]) h with saline to 24.1 (19.3-29.3 [5.0-44.0]) h when given perineurally, p = 0.00098, and to 20.9 (18.3-27.8 [8.8-31.3]) h when given intravenously, p = 0.0067. Dexamethasone increased the median (IQR [range]) time for the return of normal neurology, from 17.6 (14.0-21.0 [9.5-40.5]) h with saline to 27.5 (22.0-36.3 [7.0-53.0]) h when given perineurally, p = 0.00016, and to 24.0 (20.5-32.3 [13.0-42.5]) h when given intravenously, p = 0.0022. Dexamethasone did not affect the rates of block success, postoperative pain scores, analgesic use, or nausea and vomiting. The route of dexamethasone administration did not alter its effects.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2015 The Association of Anaesthetists of Great Britain and Ireland

License

Grant ID

Call number

Persistent link to this record